Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03783013 · ClinicalTrials.gov registry record · NA
Tomato Juice for Health Study
A NA study, sponsored by USDA Beltsville Human Nutrition Research Center.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03783013 is a NA study that was terminated before completion, run by USDA Beltsville Human Nutrition Research Center. The registered enrollment target is 19 participants.
The verdict
NCT03783013, a NA study, was terminated before completion, sponsored by USDA Beltsville Human Nutrition Research Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine if tomato-soy juice can reduce inflammation, which is linked to chronic disease
Interventions
- OTHER High Lycopene Tomato Juice With Soy Germ Extract
- OTHER Low Lycopene Tomato Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-01-08 |
| Est. Completion | 2021-08-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03783013
The ClinicalTrials.gov registry entry for NCT03783013 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA Beltsville Human Nutrition Research Center, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Lycopene Tomato Juice With Soy Germ Extract is the first listed.
NCT03783013 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03783013 about?
NCT03783013 is a clinical study titled "Tomato Juice for Health Study". The primary objective of this study is to determine if tomato-soy juice can reduce inflammation, which is linked to chronic disease
What is the current status of trial NCT03783013?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2019-01-08. Estimated completion is 2021-08-25.
What interventions are being tested in trial NCT03783013?
The interventions under investigation include: High Lycopene Tomato Juice With Soy Germ Extract (OTHER), Low Lycopene Tomato Juice (OTHER).
Who is sponsoring clinical trial NCT03783013?
This trial is sponsored by USDA Beltsville Human Nutrition Research Center, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.